临床研究
改良腹腔镜的临床有效性Fimbrioplasty最小的治疗子宫内膜异位症和不明原因的不孕
|
|
所有科目 |
年龄≤35 |
|
MLF () |
控制() |
价值 |
MLF () |
控制() |
价值 |
|
| 年龄 |
33.3±6.5 |
32.2±5.1 |
0.28 |
31.0±2.9 |
30.1±3.8 |
0.23 |
| 身体质量指数 |
25.8±5.5 |
28.2±7.8 |
0.04 |
24.9±4.6 |
28.5±7.3 |
< 0.01 |
| 种族 |
|
|
|
|
|
|
| 白色的 |
38 (80.8%) |
49 (62.0%) |
< 0.01 |
23 (76.7%) |
37 (61.7%) |
0.09 |
| 黑色的 |
3 (6.4%) |
22 (27.9%) |
3 (10.0%) |
18 (30.0%) |
| 其他人 |
6 (12.8%) |
8 (10.1%) |
4 (13.3%) |
5 (8.3%) |
| 吸烟史 |
|
|
|
|
|
|
| 曾经吸烟者 |
13 (26.0%) |
26 (29.9%) |
0.63 |
11 (33.3%) |
21 (31.8%) |
0.88 |
| 从未吸烟者 |
37 (74.0%) |
61例(70.1%) |
22 (66.7%) |
45 (68.2%) |
| 伴侣的吸烟 |
|
|
|
|
|
|
| 曾经吸烟者 |
15 (31.9%) |
23 (27.7%) |
0.61 |
10 (32.3%) |
20 (31.8%) |
0.96 |
| 从未吸烟者 |
32 (68.1%) |
60 (72.3%) |
21 (67.7%) |
43 (68.2%) |
| 长度的关系(年) |
7.9±5.1 |
6.8±4.1 |
0.20 |
7.5±5.8 |
6.3±5.4 |
0.18 |
| 妊娠 |
|
|
|
|
|
|
| 0 |
24 (48.0%) |
46 (52.9%) |
0.59 |
36 (54.5%) |
16 (48.5%) |
0.57 |
| ≥1 |
26 (52.0%) |
41 (47.1%) |
30 (45.5%) |
17 (51.6%) |
| 第三天FSH |
57±3.3 |
6.3±3.2 |
0.39 |
6.0±3.9 |
5.7±2.3 |
0.78 |
| 第三天雌二醇 |
45.1±38.4 |
36.5±27.1 |
0.22 |
50.7±45.2 |
36.7±26.6 |
0.11 |
| (OCP之前使用 |
|
|
|
|
|
|
| 是的 |
30 (78.9%) |
64例(83.1%) |
0.59 |
19 (73.1%) |
47 (82.5%) |
0.33 |
| 没有 |
8 (21.1%) |
13 (16.9%) |
7 (26.9%) |
10 (17.5%) |
| Chromopertubation |
|
|
|
|
|
|
| 专利 |
47 (97.9%) |
80例(96.4%) |
1.00 |
31 (96.9%) |
61例(98.4%) |
1.00 |
| ≥1了 |
1 (2.1%) |
3 (3.6%) |
1 (3.1%) |
1 (1.6%) |
| 精液分析 |
|
|
|
|
|
|
| 正常的 |
15 (31.3%) |
18 (26.1%) |
0.54 |
12 (37.5%) |
11 (22.0%) |
0.13 |
| 不正常的 |
33 (68.7%) |
51 (73.9%) |
20 (62.5%) |
39 (78.0%) |
|
|
注意:腹腔镜fimbrioplasty MLF =女性接受修改。(OCP =口服避孕药片。数据表示为平均数±标准差年龄、BMI,长度的关系,第三天FSH水平,第三天雌二醇水平。数据表示为分子和百分比为所有其他因素(种族、吸烟史、妊娠(OCP使用之前,chromopertubation发现,和精液分析)。p价值观得到确切概率法或双尾t以及。
|
